Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Apollomics Inc. - Warrant (NQ:APLMW)

0.0255 -0.0021 (-7.61%)
Streaming Delayed Price Updated: 1:53 PM EDT, Jul 30, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 9,500
Open 0.0233
Bid (Size) 0.0232 (2)
Ask (Size) 0.0265 (1)
Prev. Close 0.0276
Today's Range 0.0232 - 0.0347
52wk Range 0.0052 - 0.0472
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Which stocks are experiencing notable movement on Monday?
Wondering how the US markets performed one hour before the close of the markets on Monday? Discover the movers and shakers of today's session in our comprehensive analysis. 
Via Chartmill
Top stock movements in today's session.
Intrigued by the market activity in the middle of the day on Monday? Uncover the key winners and losers of today's session in our insightful analysis. 
Via Chartmill

Performance

YTD
+174.2%
+174.2%
1 Month
-42.4%
-42.4%
3 Month
+70.0%
+70.0%
6 Month
+131.8%
+131.8%
1 Year
+155.0%
+155.0%

More News

Read More
These stocks are gapping in today's session
Via Chartmill
Get insights into the top gainers and losers of Monday's pre-market session.
Via Chartmill
Gapping stocks in Thursday's session
Via Chartmill
Top movers in Tuesday's session
Via Chartmill
Top stock movements in today's session.
Via Chartmill
Here are the top movers in Monday's session.
Via Chartmill
Apollomics Reports Full Year 2024 Financial Results and Highlights Clinical Updates and Business Progress
From Apollomics Inc.
Via GlobeNewswire
Apollomics and LaunXP Announce Development and Commercialization Agreement for Vebreltinib
From Apollomics Inc.
Via GlobeNewswire
Keep an eye on the top gainers and losers in Monday's session.
Via Chartmill
Apollomics Regains Compliance with Nasdaq’s Minimum Bid Price Requirement
From Apollomics Inc.
Via GlobeNewswire
Apollomics’ Announces Shareholder Approval and Effective Date for 1-for-100 Reverse Share Split
From Apollomics Inc.
Via GlobeNewswire
Apollomics Presents Vebreltinib Data in Patients with Non-Small Cell Lung Cancer with METex14 Skipping Mutations at European Society for Medical Oncology (ESMO) Congress 2024
From Apollomics Inc.
Via GlobeNewswire
Apollomics to Present at the H.C. Wainwright 26th Annual Global Investment Conference
From Apollomics Inc.
Via GlobeNewswire
Apollomics Reports First Half 2024 Financial Results and Highlights Vebreltinib Clinical Progress
From Apollomics Inc.
Via GlobeNewswire
Apollomics Announces Positive Preliminary Data of Vebreltinib in Patients with Non-CNS MET Fusion Solid Tumors from its Phase 2 SPARTA Trial
From Apollomics Inc.
Via GlobeNewswire
Apollomics to Present at the Canaccord Genuity 44th Annual Growth Conference
From Apollomics Inc.
Via GlobeNewswire
Apollomics Granted 180-Day Extension to Regain Compliance with Nasdaq Minimum Bid Price Requirement
From Apollomics Inc.
Via GlobeNewswire
Apollomics Announces Updated Strategic Focus and Leadership Team Changes
From Apollomics Inc.
Via GlobeNewswire
Apollomics Announces Vebreltinib Data at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
From Apollomics Inc.
Via GlobeNewswire
Apollomics Announces Presentation at the 2024 BIO International Convention
From Apollomics Inc.
Via GlobeNewswire
Apollomics Announces Private Placement Financing and Addition to Board of Directors
From Apollomics Inc.
Via GlobeNewswire
Apollomics Announces Approval of Vebreltinib in China as a First-in-Class Treatment for Gliomas with MET Fusion Gene
From Apollomics Inc.
Via GlobeNewswire
Apollomics Presents Vebreltinib Data at the 2024 American Association for Cancer Research (AACR) Annual Meeting
From Apollomics Inc.
Via GlobeNewswire

Frequently Asked Questions

Is Apollomics Inc. - Warrant publicly traded?
Yes, Apollomics Inc. - Warrant is publicly traded.
What exchange does Apollomics Inc. - Warrant trade on?
Apollomics Inc. - Warrant trades on the Nasdaq Stock Market
What is the ticker symbol for Apollomics Inc. - Warrant?
The ticker symbol for Apollomics Inc. - Warrant is APLMW on the Nasdaq Stock Market
What is the current price of Apollomics Inc. - Warrant?
The current price of Apollomics Inc. - Warrant is 0.0255
When was Apollomics Inc. - Warrant last traded?
The last trade of Apollomics Inc. - Warrant was at 07/30/25 01:53 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.